Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia. (Q53765766)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia. |
scientific article |
Statements
Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia. (English)
Jan Styczynski
Wojciech Młynarski
Wojciech Fendler
Agata Pastorczak
Bartlomiej Tomasik
Joanna Trelinska
Joanna Taha
Beata Zalewska-Szewczyk
Polish Pediatric Leukemia/Lymphoma Study Group
Bernarda Kazanowska
Marta Bielska
Filip Pierlejewski
18 October 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference